Publique en esta revista
Información de la revista
Vol. 14. Núm. 1.
Páginas 27-31 (Enero - Marzo 1978)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 14. Núm. 1.
Páginas 27-31 (Enero - Marzo 1978)
DOI: 10.1016/S0300-2896(15)32640-5
Acceso a texto completo
Comentarios sobre 20 casos de cancer de pulmon operados y sobrevivientes mas de cinco años
Comentaries on 20 cases of lung cancer operated on and surviving for more than 5 years
Visitas
1255
F. Serrano Muñoz, A. Alix Trueba, A. Cueto, J.M. Borro, G. Pastor
Fundación Jiménez días. Madrid Servicio de Cirugía Torácica
Este artículo ha recibido
1255
Visitas
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen

Presentamos nuestra estadística de 20 casos de cáncer de pulmón sobrevivientes más de cinco años. Estos representan el 19% de todos los casos operados que hemos podido revisar después de cinco años. Este porcentaje no representa la totalidad de los sobrevivientes, porque muchas de las encuestas enviadas han sido devueltas por varios motivos: cambio de domicilio, paradero desconocido o muerte. Esto tiene su-explicación, puesto que la mayoría de los caso eran enfermos de la Seguridad Social, de clase humilde, procedentes de diferentes regiones españolas, y muchos de ellos sin domicilio fijo.

Si estos casos no son estadísticamente valuables, si son sin embargo motivo de consideración. Con relación a la sintomatología no hemos encontrado ninguna correlación con la sobrevivencia a los cinco años. No hemos tenido preponderancia en el tipo histológico, y, a pesar de las estadísticas generales, hemos observado sobrevivencia en dos casos de cáncer oat-cells, pero son pocos casos para sacar conclusiones definitivas.

Así mismo tenemos largas sobrevivencias en casos en los cuales el cáncer ha sobrepasado los límites del pulmón, aunque no tenemos ninguna sobrevivencia en casos con invasión masiva de los ganglios mediastínicos y pared costal.

Aunque tenemos pocos casos de nodulos solitarios y por tanto no podemos sacar conclusiones estadísticas, sí nos ha parecido que los cánceres periféricos proporcionalmente afectan menos a los ganglios mediastínicos.

A pesar de que en algún caso de los sobrevivientes hemos utilizado la ciclofosfamida, no podemos sacar conclusiones estadísticas.

En un caso avanzado se produjo un empiema, con larga sobrevivencia; tampoco hemos podido relacionar el empiema con un mejor poder inmunitario del enfermo.

Summary

The authors present their statistics of 20 cases of lung cancer surviving for more than 5 years. These represent 19% of the cases operated on that the authors were able to review after five years. This percentage does not represent the totality of the survivors because many of the questionnaires sent were returned for various reasons: change of address, no forwarding address known or death. This is to be explained by the fact that the majority of the cases were patients of the Social Security, low class, coming from different Spanish regions, and many of them with no stable residence.

Although these cases might not be valuable statistically, they are worthy of consideration. With relation to the symptomatology the authors did not find any correlation with the survival for 5 years. There was no preponderance of any histological type, and, in spite of the general statistics, the authors observed survival in two cases of cancer with oat-cells, but these are few cases for establishing definitive copdusions. in which the cancer spread beyond the limits of the lung, although in this series there are no survivors in cases of massive invasion of the mediastinal nodes and costal wall.

Although there were few cases of solitary nodes and therefore the authors cannot formulate statistical conclusions, it did seem to them that the peripherical cancers proportionally affect the mediastinal nodes less.

Although the authors did use cyclophosphamide in some case, they cannot formúlate statistical conclusions.

In one advanced case there was an empyema with long survival; the authors were unable to relate the empyema with a better immunitary power of the patient.

El Texto completo está disponible en PDF
Bibliografia
[1.]
N.I. Berlin.
Early detection and localization of bronchogenic carcinoma.
Chest, 67 (1975), pp. 508
[2.]
R.S. Fontana, D.R. Sanderson, L.B. Wooler, Ph.E. Bernatz, W.F. Taylor.
The Mayo lung project for early detection and localization of bronchogenic carcinoma. A stadistic report.
Chest, 67 (1975), pp. 511
[3.]
G. Higgins, G.B. Deebe, T.H.W. Shields, R.J. Keehn.
The solitary pulmonary nodule. Ten-year follow-up of veterans Administration Armed Forces cooperative study.
Arch. Surg, 110 (1975), pp. 570
[4.]
H.D. Stanford, G.C.H. Spivey, L.L. Gordon, J.A. Alexander, H.J. Besic.
Results of treatment of primary carcinoma of the lung Analysis of 3.000 cases.
J. Thorac. Cardiovasc. Surg, 72 (1976), pp. 441
[5.]
R.J. Jackman, A. Good, O.T.H. Clagett, P. Woolmer.
Survival rates in peripheral bronchogenic carcinomas up to four centimeters in diameter presenting as solitary pulmonary nodules..
J. Thorac. Cardiovasc., Surg, 57 (1969), pp. 1
[6.]
D.L. Paulson, J.S. Reisch.
Long term survival after resection for bronchogenic carcinoma.
Ann. Surg., 184 (1976), pp. 324
[7.]
M. Bates.
Segmental resection for bronchial carcinoma.
Thorax, 30 (1975), pp. 234
[8.]
M.S. Didolkar, R.H. Moore, H. Takita.
Evaluation of the risk on pulmonary resection for bronchogenic carcinoma.
Am. J. Surg, 127 (1974), pp. 700
[9.]
M.M. Kirsh, H. Rotman, L. Argenta, E. Bove, V. Cimmino, J. Tashian, N.P. Ferguso.
Carcinoma of the lung Results of treatment over then years.
Am. Thorac. Surg, 21 (1976), pp. 371
[10.]
K. Kokila, T. Lehtonen.
Evaluation of arterial blood gases in pulmonary carcinoma..
Scand. J., Thorac. Cardiov. Surg, 8 (1974), pp. 216
[11.]
J.S. Karlinger, R. Coomaraswamy, M.H. Williams.
Relationship between preoperative pulmonary function studies and prognosis of patients undergoing pneumonectomy for carcinoma of the lung.
Dis. Chest, 54 (1968), pp. 32
[12.]
F. Serrano Munoz, A. Alix True Ba, A. Cueto, J.L. Bermudez.
Rentabilidad de la mediastinoscopia, mediastinostomía y pequeña toracotomía transversal, como indicación quirúrgica en el cáncer de pulmón.
Bol. Fundac. Jimenez Días, 7 (1975), pp. 29
[13.]
F. Serrano Munox, J. Toledo Gonzalez, A. Alix Trueba.
Cáncer de pulmón.
Bol. Fundac. Jimenez Díaz, 5 (1973), pp. 105
[14.]
N. Roeslin, J.P. Witz, G. Morand, Ch. Irrmann-Rapp.
Traitment chirurgical par excision «monobloc» des cancers bronchiques envashissant le paroi thoracique.
Ann. Chir. Thorac. Cardiov. Surg, 15 (1976), pp. 19
[15.]
F.G. Bloedorm, R.A. Cowley, C.A. Cuccia, R. Mercado.
Rationale and benefít of preoperative irradiation in lung cáncer.
JAMA, 196 (1966), pp. 340
[16.]
N. Abranson, .P.J. Cavanaugh.
Short course radiation therapy in carcinoma of the lung.
Radiology, 96 (1970), pp. 627
[17.]
D.L. Paulson, P.R. Shaw, J.L. Kee.
Treatment of superior sulcus tumor by irradiation followed by resection.
Ann. Surg, 154 (1961), pp. 129
[18.]
F. Serrano Munox.
Lobectomía en el tratamiento del cáncer de pulmón.
Rev. Clin.Esp, 83 (1961), pp. 239
[19.]
D.L. Paulson, H.C. Urschell.
Selectivity in the surgical treatment of bronchogenic carcinoma.
J. Thorac, Cardiovasc. Surg, 62 (1971), pp. 554
[20.]
A.P. Naef, M. Gaden.
L’exerese economique bronchique ou pulmonaire dans le traitement du cancer du poumon.
Schweiz Med. Wochenschr, 105 (1975), pp. 1.126
[21.]
T.W. Shields, J. Yeu, J.N. Conn, C.D. Robinette.
Relationship of cell type and lymph node metastasis to survival after resection of bronchial carcinoma.
Ann. Thorac. Surg, 20 (1975), pp. 501
[22.]
R.S. Jensik, L.P. Faber, F.J. Milloy, J.L. Amato.
Sleeve lobectomy for carcinoma. A ten year experience.
J. Thorac. Cardiovasc. Surg, 64 (1972), pp. 400
[23.]
J.C. Jones, J.L. Robinson, B.W. Meyen, H.C. Motley.
Primary carcinoma of the lung.
J. Thorac. Cardiovasc. Surg, 39 (1960), pp. 144
[24.]
T. Overholt, W.B. Neptune, M.M. Ashraf.
Primary cancer of lung. A 42 year experience.
Ann. Thorac. Surg, 20 (1975), pp. 511
[25.]
N. SchiLeben.
Diagnostik un chirurgische therapie des Bronchialkarzinous: Bericht uber 1000 Falle.
Munch Med. Wochenschi, 117 (1975), pp. 293
[26.]
M.V. Inberg, J. Klossner, M.I. Linna, E. Tala, S.J. Viikari.
Facilities for surgery and survival prospect in lung carcinoma: a study from South West Finland between 1953 to.
Scand. J. Thorac. Cardiov. Surg., 6 (1970), pp. 297
[27.]
L. Brock.
Long suvival after operadon of cancer of the lung.
Brit. Journ. Surg, 62 (1975), pp. 1
[28.]
J.L. Pool.
Survival in lung cancer: effectiveness of surgery.
N.Y. State J. Med, 71 (1971), pp. 2045
[29.]
L.M. Matthews.
Frequency of residual and metastatic tumors in patients undergoing curative resection for lung cancer.
Cancer Chemother, 4 (1973), pp. 63
[30.]
R.R. Baker, P.S. Frederick, B.R. Marsh.
The clinical assement of selected patients with bronchogenic carcinoma.
Ann. Thorac. Surg, 20 (1975), pp. 321
[31.]
R.S. Fontana.
Early bronchogenic carcinoma.
Surg. Clin. North. Am, 53 (1975), pp. 761
[32.]
D.L. Paulson.
Selection of patients for surgery for bronchogenic carcinoma.
Amer. Surg, 39 (1973), pp. 1
[33.]
W.R. Gurevich.
Rates of growth of peripheral carcinoma of the lung and their significance.
Journ. Roent. Radiol., 6 (1975), pp. 52
[34.]
W. Weiss.
Operative mortality and five year survival rates in patients with bronchogenic carcinoma.
Am. J. Sur, 128 (1974), pp. 799
[35.]
P.G. Pearson, J.M. Helens, A. Anderson, N.C. Dela Rue.
The role of mediastinoscopy in the treatment of bronchial carcinoma with involment of superior mediastinal lymph nodes.
J. Thorac. Cardiovasc. Surg, 64 (1972), pp. 382
[36.]
H.A. Wellons, G. Johnson, W.R. Benson, D. Pate.
Pronostic factors in malignant tumors of the lung.
Ann. Thorac. Surg, 5 (1968), pp. 288
[37.]
H.J. Wanedo, N. Miyazawa, N. Martini, M. Middleman, F. Dettgen.
Inmune reactivity in primary carcinoma of the lungs and its relation to prognosis.
J. Thorac. Carciovasc. Surg., 72 (1976), pp. 339
[38.]
D. Price-Evans.
Inmunological of bronchial carcinoma.
Thorac, 31 (1976), pp. 493
[39.]
M.F. Mckneally, C. Maver, H.W. Kausel, R.D. Alley.
Regional inmunotherapy with intrapleural B.C.G. for lung cáncer Surgical considerations.
J. Thorac. Cardiovasc. Surg, 72 (1976), pp. 333
[40.]
A. Pines.
A 5 years controlled study of B.C.G. and radiotherapy for inoperable lung cancer.
Lancet, 1 (1976), pp. 380
[41.]
Study group for bronchogenic carcinoma..
Inmunopotentialization with levamisole in resectable bronchogenic carcinoma a double blind controlled trial.
Brit. Medie. J, 3 (1975), pp. 461
[42.]
E.J. Beattie, M.S. Bains, N. Martini.
Tratamiento de las lesiones numulares malignas primarias del pulmón».
Clinic, Quirurg. de Ñor. Amer., Agosto, (1976),
[43.]
M.V. Inberg, J. Klossner, M.I. Linna, E. Pukakkatala, S.J. Vilkari.
The role of mediastinoscopy in the treatment of lung carcinoma.
J. Thorac. Cardiovasc. Surg, 6 (1972), pp. 293
[44.]
J. Yashar, J.J. Jashar.
Factors effecting long-term survival of patients with bronchogenic carcinoma.
Am. J. Surg, 129 (1975), pp. 386
[45.]
G.L. Ashor, W.H. Kern, B.W. Meyer, G.G. Lindesmith, Q.R. Stiles, B.L. Tucker, J.C. Jones.
J. Thorac. Cardiovasc., Surg, 70 (1975), pp. 581
[46.]
T.S. Naruke, K. Suemasu, S.H. Ishikawa.
Surgical treatment for lung cancer with methastasis to mediastinal lymph nodes.
J. Thorac. Cardiovasc. Surg, 71 (1976), pp. 279
[47.]
M.M. Kirsh, D.R. Kahn, O. Gago.
The effect of histological cell type in the prognosis of patients with bronchogenic carcinoma.
Ann. Thorac. Surg, 13 (1972), pp. 303
[48.]
M.M. Kirsh, H. Rotman, L. Argenta, E. Bove, V. Cimmino, S.B. Tashian Ferguson, H. Sloan.
Carcinoma of the lung Results of treatment over ten years Ann.
Thorac. Surg., 21 (1976), pp. 371
[49.]
L. Lince, D.J. Lulu.
Carcinoma of the lung. A comparative series of 687 cases.
Arch. of Surgery, 102 (1971), pp. 103
[50.]
Abbey Smith, J. Comunicación personal
[51.]
F. Serrano Munox, A. Alix True-Ba, A. Cueto, J.L. Fernandez-Bermudez.
Cirugía traqueobronquial en el cancer de pulmón.
Arch. Bronconeumol, 10 (1974), pp. 133
Copyright © 1978. Sociedad Española de Neumología y Cirugía Torácica
Idiomas
Archivos de Bronconeumología

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.